260 related articles for article (PubMed ID: 6967946)
1. Evidence for a new segregant series of B cell antigens that are encoded in the HLA-D region and that stimulate secondary allogenic proliferative and cytotoxic responses.
Shaw S; Johnson AH; Shearer GM
J Exp Med; 1980 Sep; 152(3):565-80. PubMed ID: 6967946
[TBL] [Abstract][Full Text] [Related]
2. HLA-linked B cell alloantigens of a new segregant series: population and family studies of the SB antigens.
Shaw S; Pollack MS; Payne SM; Johnson AH
Hum Immunol; 1980 Sep; 1(2):177-85. PubMed ID: 6973559
[TBL] [Abstract][Full Text] [Related]
3. Serologic identification of the human secondary B cell antigens. Correlations between function, genetics, and structure.
Shaw S; DeMars R; Schlossman SF; Smith PL; Lampson LA; Nadler LM
J Exp Med; 1982 Sep; 156(3):731-43. PubMed ID: 6809881
[TBL] [Abstract][Full Text] [Related]
4. Possible involvement of the OKT4 molecule in T-cell recognition of class II HLA antigens.
Biddison WE; Shaw S
Diagn Immunol; 1983; 1(3):112-5. PubMed ID: 6209053
[TBL] [Abstract][Full Text] [Related]
5. Expression of HLA-C molecules confers target cell resistance to some non-major histocompatibility complex-restricted T cells in a manner analogous to allospecific natural killer cells.
Falk CS; Steinle A; Schendel DJ
J Exp Med; 1995 Oct; 182(4):1005-18. PubMed ID: 7561674
[TBL] [Abstract][Full Text] [Related]
6. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
Yasukawa M; Zarling JM
J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
[TBL] [Abstract][Full Text] [Related]
7. Alloactivated long-term cultured human T lymphocytes express both HLA-DR and SB antigens but lack lymphocyte stimulation capacity.
Pawelec G; Blaurock M; Schneider EM; Shaw S; Wernet P
Eur J Immunol; 1982 Nov; 12(11):967-72. PubMed ID: 6983971
[TBL] [Abstract][Full Text] [Related]
8. Possible involvement of the T4 molecule in T cell recognition of class II HLA antigens: evidence from studies of proliferative responses to SB antigens.
Biddison WE; Rao PE; Talle MA; Goldstein G; Shaw S
J Immunol; 1983 Jul; 131(1):152-7. PubMed ID: 6190904
[TBL] [Abstract][Full Text] [Related]
9. A new B-cell alloantigen, TB21, coded for in the HLA-D/DR region.
Maeda H; Juji T
Tissue Antigens; 1982 Nov; 20(5):327-34. PubMed ID: 6818712
[TBL] [Abstract][Full Text] [Related]
10. Relation of insulin-dependent diabetes mellitus (IDD) and the HLA-linked SB system.
de Jongh BM; Termijtelen A; Bruining GJ; de Vries RR; van Rood JJ
Tissue Antigens; 1984 Feb; 23(2):87-93. PubMed ID: 6608807
[TBL] [Abstract][Full Text] [Related]
11. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
[TBL] [Abstract][Full Text] [Related]
12. Cell mediated cytotoxicity against HLA-D region products expressed in monocytes and B lymphocytes. III. Inhibition by monoclonal antibodies and study of an HLA-B/DR recombinant.
Ball EJ; Feighery CF; Stastny P
Hum Immunol; 1981 Jul; 2(4):305-13. PubMed ID: 6974159
[TBL] [Abstract][Full Text] [Related]
13. Homogeneity of the HLA-linked SB2 and SB3 specificities demonstrated by cloned alloreactive T cells.
Pawelec G; Shaw S; Schneider M; Rehbein A; Wernet P
Immunogenetics; 1983; 17(2):179-88. PubMed ID: 6402448
[TBL] [Abstract][Full Text] [Related]
14. Evidence for the involvement of HLA-DR antigens in restricted cytotoxicity by fetal calf serum-specific human T cells.
Misko IS; Pope JH; Kane RG; Bashir H; Doran T
Hum Immunol; 1982 Nov; 5(3):183-97. PubMed ID: 6184349
[TBL] [Abstract][Full Text] [Related]
15. Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2).
Ciccone E; Pende D; Viale O; Than A; Di Donato C; Orengo AM; Biassoni R; Verdiani S; Amoroso A; Moretta A
J Exp Med; 1992 Oct; 176(4):963-71. PubMed ID: 1328466
[TBL] [Abstract][Full Text] [Related]
16. Functional cell mediated lympholysis: II. Genetics.
Goeken NE; Thompson JS
Tissue Antigens; 1981; 17(4):411-20. PubMed ID: 6949337
[TBL] [Abstract][Full Text] [Related]
17. Activation of human T lymphocyte subsets: helper and suppressor/cytotoxic T cells recognize and respond to distinct histocompatibility antigens.
Engleman EG; Benike CJ; Grumet FC; Evans RL
J Immunol; 1981 Nov; 127(5):2124-9. PubMed ID: 6457863
[TBL] [Abstract][Full Text] [Related]
18. T-cell proliferation and expression of MHC class II antigens.
Brown G; Walker L; Ling NR; Richardson P; Johnson GD; Guy K; Steel CM
Scand J Immunol; 1984 Apr; 19(4):373-7. PubMed ID: 6610209
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
[TBL] [Abstract][Full Text] [Related]
20. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
